Myomaker Bio develops lab-grown human skeletal muscle platforms for preclinical drug testing.
Myomaker Bio has raised $434K in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Myomaker Bio's investors include SFC Capital.
Myomaker Bio is headquartered in Loughborough, United Kingdom.
Myomaker Bio develops lab-grown human skeletal muscle platforms for preclinical drug testing.
Myomaker Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Myomaker Bio — Funding & Investors." VCBacked, March 12, 2026, https://www.vcbacked.co/company/myomaker-bio. Accessed November 15, 2026.
VCBacked. (2026). Myomaker Bio — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/myomaker-bio
{{cite web |title=Myomaker Bio — Funding & Investors |url=https://www.vcbacked.co/company/myomaker-bio |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Myomaker Bio? Request a listing update